908 Devices Inc. Common Stock (MASS) is a publicly traded Healthcare sector company. As of May 21, 2026, MASS trades at $6.98 with a market cap of $251.08M and a P/E ratio of -7.03. MASS moved +3.02% today. Year to date, MASS is +27.37%; over the trailing twelve months it is +41.30%. Its 52-week range spans $1.81 to $9.34. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces MASS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
908 Devices Posts 21% Q4 Revenue Growth and Positive EBITDA: 908 Devices shipped 224 handheld analyzers in Q4, lifting its installed base to 3,736 units and raising continuing-operations revenue 21% year over year to $17.4 million, while driving adjusted EBITDA to a positive $0.7 million from a prior $4.0 million loss. Full-year 2025 revenue rose 18% to $56.2 million with recurring revenue at 35% of sales, ending the year with $113 million in cash and no debt, and management forecasts 2026 revenue growth of 15–20% to $64.5–67.5 million.
| Metric | Value |
|---|---|
| Price | $6.98 |
| Market Cap | $251.08M |
| P/E Ratio | -7.03 |
| EPS | $-0.99 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.34 |
| 52-Week Low | $1.81 |
| Volume | 769 |
| Avg Volume | 0 |
| Revenue (TTM) | $57.80M |
| Net Income | $-36.07M |
| Gross Margin | 51.49% |
3 analysts cover MASS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.